Literature DB >> 645175

Immunological studies of hsv-infection of resistant and susceptible inbred strains of mice.

H Kirschner, M Kochen, H M Hirt, K Munk.   

Abstract

DBA/2 mice were found to be quite susceptible to infection with herpes simplex virus (HSV) while C57BL/6 mice and F1 hybrids between the 2 strains were relatively resistant. This difference was most marked after ip infection, but could also be demonstrated after intracerebral, intravenous or subcutaneous infection. In both strains the LD50 was considerably higher after ip infection than after iv infection, and a dose of X-irradiation was required to kill the mice by sc infection. A/J and BALB/c mice were equally susceptible after ip infection but differed significantly after iv infection. C57BL/6 were made susceptible to ip infection by immunosuppression with antilymphocyte serum or cyclophosphamide. LPS, when given simultaneously with HSV also markedly increased the susceptibility of C57BL/6 mice. Susceptible DBA/2 mice which surrvived a low dose of HSV ip were not immune but C57BL/6 mice surviving a high dose were immune against rechallenge. Both strains of mice could be protected by an apathogenic, tissue-culture-attenuated strain of HSV against infection with the virulent strain. They could also be protected by iv injection of a sublethal dose against a lethal ip infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 645175

Source DB:  PubMed          Journal:  Z Immunitatsforsch Immunobiol        ISSN: 0340-904X


  10 in total

1.  Protection of mice against mouse hepatitis virus by Corynebacterium parvum.

Authors:  L Schindler; G Streissle; H Kirchner
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

2.  Innate Mucosal Immune System Response of BALB/c vs C57BL/6 Mice to Injury in the Setting of Enteral and Parenteral Feeding.

Authors:  Rebecca A Busch; Mark A Jonker; Joseph F Pierre; Aaron F Heneghan; Kenneth A Kudsk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-11-17       Impact factor: 4.016

3.  Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

Authors:  E Paoletti; B R Lipinskas; C Samsonoff; S Mercer; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a nonpathogenic herpes simplex virus type 1 virus strain in mouse brain.

Authors:  H C Kaerner; C H Schröder; A Ott-Hartmann; G Kümel; H Kirchner
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

5.  Resistance to infections in mice with defects in the activities of mononuclear phagocytes and natural killer cells: effects of immunomodulators in beige mice and 89Sr-treated mice.

Authors:  P S Morahan; P H Coleman; S S Morse; A Volkman
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2.

Authors:  L Caspary; B Schindling; S Dundarov; D Falke
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production.

Authors:  E B Pedersen; S Haahr; S C Mogensen
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

8.  Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes.

Authors:  M J Lawman; B T Rouse; R J Courtney; R D Walker
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

9.  Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice.

Authors:  H Engler; R Zawatzky; H Kirchner; D Armerding
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

10.  Pathogenesis of Herpes simplex virus infections in guinea pigs.

Authors:  M Scriba; F Tatzber
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.